Earnings Releases·Nov 9, 2026, 8:01 AM ET

Turning Point Brands — Third Quarter 2026 Earnings Summary

Total consolidated net sales rose 27.0% year-over-year to $151.1 million, driven by a 102.9% surge in Modern Oral net sales and a 52.0% increase in Stoker's, though Zig-Zag sales fell 15.5%.
Net income and Adjusted EBITDA declined significantly by 81.4% and 41.3% respectively to $3.9 million and $18.4 million, primarily due to a 69.1% increase in SG&A expenses and margin compression from product mix shifts.
Management reaffirmed full-year 2026 guidance for Modern Oral Net Sales ($260-$270 million) and Adjusted EBITDA ($70-$80 million), citing strong positioning in the nicotine pouch category.
The company repurchased 167,161 shares for $10.0 million during the quarter, maintaining a total liquidity position of $322.8 million.